CombinatoRx homepage. [http://www.combinatorx.com]
Zimmermann GR, Avery W, Finelli AL, Farwell M, Fraser CC, Borisy AA: Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug. Arthritis Res Ther. 2009, 11: R12-10.1186/ar2602.
Article
PubMed Central
PubMed
Google Scholar
Kirwan JR, Bijlsma JW, Boers M, Shea BJ: Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007, CD006356-1
Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Inês LB, de Koning EJ, Buttgereit F, Cutolo M, Capell H, Rau R, Bijlsma JW: Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006, 65: 285-293. 10.1136/ard.2005.038638.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Haf-strom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007, 66: 1560-1567. 10.1136/ard.2007.072157.
Article
PubMed Central
CAS
PubMed
Google Scholar
Krogsgaard MR, Thamsborg G, Lund B: Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort. Ann Rheum Dis. 1996, 55: 143-146. 10.1136/ard.55.2.143.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet. 2008, 371: 205-214. 10.1016/S0140-6736(08)60132-4.
Article
CAS
PubMed
Google Scholar
Bijlsma JW, Jacobs JW: Glucocorticoid chronotherapy in rheumatoid arthritis. Lancet. 2008, 371: 183-184. 10.1016/S0140-6736(08)60114-2.
Article
PubMed
Google Scholar
Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056/NEJMra050541.
Article
CAS
PubMed
Google Scholar
Koning GA, Schiffelers RM, Wauben MH, Kok RJ, Mastrobattista E, Molema G, ten Hagen TL, Storm G: Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 2006, 54: 1198-1208. 10.1002/art.21719.
Article
CAS
PubMed
Google Scholar
Bijlsma JW, Saag KG, Buttgereit F, da Silva JA: Developments in glucocorticoid therapy. Rheum Dis Clin North Am. 2005, 31: 1-17. 10.1016/j.rdc.2004.10.003.
Article
PubMed
Google Scholar